MDxHealth (MDXH) Competitors

$0.80 0.00 (0.00%)

Closing price 05/22/2026 04:00 PM Eastern

Extended Trading

$0.82 +0.02 (+2.50%)

As of 05/22/2026 07:37 PM Eastern

MDXH vs. TBRG, LAB, SOPH, KRMD, and ZEPP

Should you buy MDxHealth stock or one of its competitors? MarketBeat compares MDxHealth with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with MDxHealth include TruBridge (TBRG), Standard BioTools (LAB), SOPHiA GENETICS (SOPH), KORU Medical Systems (KRMD), and Zepp Health (ZEPP). These companies are all part of the "medical info sys" industry.

How does MDxHealth compare to TruBridge?

TruBridge (NASDAQ:TBRG) and MDxHealth (NASDAQ:MDXH) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, valuation, dividends, profitability, earnings, institutional ownership and risk.

TruBridge currently has a consensus price target of $23.95, suggesting a potential downside of 7.67%. MDxHealth has a consensus price target of $4.63, suggesting a potential upside of 478.13%. Given MDxHealth's stronger consensus rating and higher possible upside, analysts plainly believe MDxHealth is more favorable than TruBridge.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TruBridge	0 Sell rating(s)	7 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.25
MDxHealth	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

In the previous week, TruBridge had 5 more articles in the media than MDxHealth. MarketBeat recorded 5 mentions for TruBridge and 0 mentions for MDxHealth. TruBridge's average media sentiment score of 0.14 beat MDxHealth's score of 0.00 indicating that TruBridge is being referred to more favorably in the media.

Company	Overall Sentiment
TruBridge	Neutral
MDxHealth	Neutral

TruBridge has a beta of 1.3, meaning that its stock price is 30% more volatile than the broader market. Comparatively, MDxHealth has a beta of 1.6, meaning that its stock price is 60% more volatile than the broader market.

88.6% of TruBridge shares are held by institutional investors. 10.7% of TruBridge shares are held by company insiders. Comparatively, 1.7% of MDxHealth shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

TruBridge has a net margin of 0.92% compared to MDxHealth's net margin of -29.90%. TruBridge's return on equity of 18.75% beat MDxHealth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
TruBridge	0.92%	18.75%	8.32%
MDxHealth	-29.90%	-1,078.01%	-22.51%

TruBridge has higher revenue and earnings than MDxHealth. MDxHealth is trading at a lower price-to-earnings ratio than TruBridge, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TruBridge	$346.84M	1.12	$4.21M	$0.20	129.70
MDxHealth	$107.88M	0.37	-$33.52M	-$0.65	N/A

Summary

TruBridge beats MDxHealth on 13 of the 17 factors compared between the two stocks.

How does MDxHealth compare to Standard BioTools?

MDxHealth (NASDAQ:MDXH) and Standard BioTools (NASDAQ:LAB) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, risk, media sentiment, profitability, valuation, dividends and earnings.

In the previous week, Standard BioTools had 1 more articles in the media than MDxHealth. MarketBeat recorded 1 mentions for Standard BioTools and 0 mentions for MDxHealth. Standard BioTools' average media sentiment score of 0.95 beat MDxHealth's score of 0.00 indicating that Standard BioTools is being referred to more favorably in the news media.

Company	Overall Sentiment
MDxHealth	Neutral
Standard BioTools	Positive

53.7% of Standard BioTools shares are owned by institutional investors. 1.7% of MDxHealth shares are owned by insiders. Comparatively, 23.2% of Standard BioTools shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Standard BioTools has a net margin of 73.46% compared to MDxHealth's net margin of -29.90%. Standard BioTools' return on equity of -8.18% beat MDxHealth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
MDxHealth	-29.90%	-1,078.01%	-22.51%
Standard BioTools	73.46%	-8.18%	-6.43%

MDxHealth has a beta of 1.6, suggesting that its stock price is 60% more volatile than the broader market. Comparatively, Standard BioTools has a beta of 1.32, suggesting that its stock price is 32% more volatile than the broader market.

MDxHealth has higher revenue and earnings than Standard BioTools. MDxHealth is trading at a lower price-to-earnings ratio than Standard BioTools, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
MDxHealth	$107.88M	0.37	-$33.52M	-$0.65	N/A
Standard BioTools	$85.33M	4.71	-$74.90M	$0.20	5.15

MDxHealth presently has a consensus target price of $4.63, indicating a potential upside of 478.13%. Standard BioTools has a consensus target price of $1.35, indicating a potential upside of 31.07%. Given MDxHealth's stronger consensus rating and higher probable upside, analysts plainly believe MDxHealth is more favorable than Standard BioTools.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
MDxHealth	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50
Standard BioTools	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67

Summary

Standard BioTools beats MDxHealth on 10 of the 16 factors compared between the two stocks.

How does MDxHealth compare to SOPHiA GENETICS?

SOPHiA GENETICS (NASDAQ:SOPH) and MDxHealth (NASDAQ:MDXH) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, risk, valuation, media sentiment, analyst recommendations, dividends and earnings.

MDxHealth has higher revenue and earnings than SOPHiA GENETICS. SOPHiA GENETICS is trading at a lower price-to-earnings ratio than MDxHealth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SOPHiA GENETICS	$77.27M	4.33	-$79M	-$0.52	N/A
MDxHealth	$107.88M	0.37	-$33.52M	-$0.65	N/A

MDxHealth has a net margin of -29.90% compared to SOPHiA GENETICS's net margin of -44.48%. SOPHiA GENETICS's return on equity of -62.74% beat MDxHealth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SOPHiA GENETICS	-44.48%	-62.74%	-21.85%
MDxHealth	-29.90%	-1,078.01%	-22.51%

SOPHiA GENETICS currently has a consensus target price of $7.50, indicating a potential upside of 53.69%. MDxHealth has a consensus target price of $4.63, indicating a potential upside of 478.13%. Given MDxHealth's stronger consensus rating and higher possible upside, analysts plainly believe MDxHealth is more favorable than SOPHiA GENETICS.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SOPHiA GENETICS	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
MDxHealth	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

SOPHiA GENETICS has a beta of 1.01, indicating that its share price is 1% more volatile than the broader market. Comparatively, MDxHealth has a beta of 1.6, indicating that its share price is 60% more volatile than the broader market.

31.6% of SOPHiA GENETICS shares are held by institutional investors. 4.9% of SOPHiA GENETICS shares are held by insiders. Comparatively, 1.7% of MDxHealth shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, SOPHiA GENETICS had 1 more articles in the media than MDxHealth. MarketBeat recorded 1 mentions for SOPHiA GENETICS and 0 mentions for MDxHealth. SOPHiA GENETICS's average media sentiment score of 0.00 equaled MDxHealth'saverage media sentiment score.

Company	Overall Sentiment
SOPHiA GENETICS	Neutral
MDxHealth	Neutral

Summary

MDxHealth beats SOPHiA GENETICS on 8 of the 15 factors compared between the two stocks.

How does MDxHealth compare to KORU Medical Systems?

KORU Medical Systems (NASDAQ:KRMD) and MDxHealth (NASDAQ:MDXH) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, institutional ownership, risk, earnings, profitability, media sentiment, valuation and analyst recommendations.

KORU Medical Systems has a beta of 0.43, meaning that its stock price is 57% less volatile than the broader market. Comparatively, MDxHealth has a beta of 1.6, meaning that its stock price is 60% more volatile than the broader market.

KORU Medical Systems has higher earnings, but lower revenue than MDxHealth. KORU Medical Systems is trading at a lower price-to-earnings ratio than MDxHealth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
KORU Medical Systems	$41.13M	4.58	-$2.64M	-$0.05	N/A
MDxHealth	$107.88M	0.37	-$33.52M	-$0.65	N/A

58.6% of KORU Medical Systems shares are owned by institutional investors. 18.5% of KORU Medical Systems shares are owned by insiders. Comparatively, 1.7% of MDxHealth shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

KORU Medical Systems has a net margin of -5.27% compared to MDxHealth's net margin of -29.90%. KORU Medical Systems' return on equity of -13.61% beat MDxHealth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
KORU Medical Systems	-5.27%	-13.61%	-8.33%
MDxHealth	-29.90%	-1,078.01%	-22.51%

KORU Medical Systems currently has a consensus price target of $7.25, indicating a potential upside of 76.83%. MDxHealth has a consensus price target of $4.63, indicating a potential upside of 478.13%. Given MDxHealth's higher possible upside, analysts clearly believe MDxHealth is more favorable than KORU Medical Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
KORU Medical Systems	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60
MDxHealth	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

In the previous week, KORU Medical Systems had 4 more articles in the media than MDxHealth. MarketBeat recorded 4 mentions for KORU Medical Systems and 0 mentions for MDxHealth. KORU Medical Systems' average media sentiment score of 0.97 beat MDxHealth's score of 0.00 indicating that KORU Medical Systems is being referred to more favorably in the media.

Company	Overall Sentiment
KORU Medical Systems	Positive
MDxHealth	Neutral

Summary

KORU Medical Systems beats MDxHealth on 11 of the 15 factors compared between the two stocks.

How does MDxHealth compare to Zepp Health?

Zepp Health (NYSE:ZEPP) and MDxHealth (NASDAQ:MDXH) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, institutional ownership, profitability, media sentiment, dividends and earnings.

In the previous week, Zepp Health had 2 more articles in the media than MDxHealth. MarketBeat recorded 2 mentions for Zepp Health and 0 mentions for MDxHealth. Zepp Health's average media sentiment score of 0.00 equaled MDxHealth'saverage media sentiment score.

Company	Overall Sentiment
Zepp Health	Neutral
MDxHealth	Neutral

Zepp Health has a beta of 2, meaning that its stock price is 100% more volatile than the broader market. Comparatively, MDxHealth has a beta of 1.6, meaning that its stock price is 60% more volatile than the broader market.

Zepp Health currently has a consensus target price of $56.28, indicating a potential upside of 552.22%. MDxHealth has a consensus target price of $4.63, indicating a potential upside of 478.13%. Given Zepp Health's higher probable upside, equities research analysts clearly believe Zepp Health is more favorable than MDxHealth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zepp Health	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
MDxHealth	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

MDxHealth has lower revenue, but higher earnings than Zepp Health. Zepp Health is trading at a lower price-to-earnings ratio than MDxHealth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zepp Health	$258.90M	0.49	-$40.07M	-$2.51	N/A
MDxHealth	$107.88M	0.37	-$33.52M	-$0.65	N/A

Zepp Health has a net margin of -15.48% compared to MDxHealth's net margin of -29.90%. Zepp Health's return on equity of -15.00% beat MDxHealth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Zepp Health	-15.48%	-15.00%	-6.07%
MDxHealth	-29.90%	-1,078.01%	-22.51%

52.6% of Zepp Health shares are owned by institutional investors. 36.0% of Zepp Health shares are owned by insiders. Comparatively, 1.7% of MDxHealth shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

Zepp Health beats MDxHealth on 10 of the 15 factors compared between the two stocks.

Get MDxHealth News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MDXH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

MDXH vs. The Competition

Export

Metric	MDxHealth	MEDICAL INFO SYS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$39.60M	$1.44B	$6.46B	$12.34B
Dividend Yield	N/A	N/A	2.76%	5.28%
P/E Ratio	-1.23	64.56	21.22	25.66
Price / Sales	0.37	6.30	562.28	86.31
Price / Cash	N/A	22.72	43.49	56.67
Price / Book	-1.95	7.38	10.31	7.14
Net Income	-$33.52M	-$54.76M	$3.57B	$335.98M
7 Day Performance	-4.68%	3.02%	6.43%	4.15%
1 Month Performance	-61.54%	6.69%	3.57%	2.54%
1 Year Performance	-60.78%	1.47%	34.07%	35.06%

MDxHealth Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MDXH MDxHealth	2.5556 of 5 stars	$0.80 flat	$4.63 +478.1%	-60.8%	$39.60M	$107.88M	N/A	300	Gap Up
TBRG TruBridge	2.7124 of 5 stars	$25.89 flat	$23.95 -7.5%	+9.3%	$388.32M	$345.90M	129.45	3,500
LAB Standard BioTools	3.0571 of 5 stars	$1.01 +2.0%	$1.35 +33.7%	+11.8%	$386.46M	$86.26M	5.05	620
SOPH SOPHiA GENETICS	1.9715 of 5 stars	$4.63 -3.3%	$7.50 +62.0%	+71.2%	$328.05M	$77.27M	N/A	520
KRMD KORU Medical Systems	4.4219 of 5 stars	$4.00 -0.5%	$7.25 +81.3%	+54.1%	$184.65M	$41.13M	N/A	80

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:MDXH) was last updated on 5/26/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

MDxHealth (MDXH) Competitors

MDXH vs. TBRG, LAB, SOPH, KRMD, and ZEPP

How does MDxHealth compare to TruBridge?

Summary

How does MDxHealth compare to Standard BioTools?

Summary

How does MDxHealth compare to SOPHiA GENETICS?

Summary

How does MDxHealth compare to KORU Medical Systems?

Summary

How does MDxHealth compare to Zepp Health?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MDXH vs. The Competition

MDxHealth Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

MDxHealth (MDXH) Competitors

MDXH vs. TBRG, LAB, SOPH, KRMD, and ZEPP

How does MDxHealth compare to TruBridge?

Do analysts rate TBRG or MDXH?

Does the media favor TBRG or MDXH?

Which has more volatility and risk, TBRG or MDXH?

Do institutionals & insiders hold more shares of TBRG or MDXH?

Is TBRG or MDXH more profitable?

Which has preferable earnings & valuation, TBRG or MDXH?

Summary

How does MDxHealth compare to Standard BioTools?

Does the media prefer MDXH or LAB?

Do institutionals & insiders have more ownership in MDXH or LAB?

Is MDXH or LAB more profitable?

Which has more risk and volatility, MDXH or LAB?

Which has stronger valuation & earnings, MDXH or LAB?

Do analysts recommend MDXH or LAB?

Summary

How does MDxHealth compare to SOPHiA GENETICS?

Which has stronger valuation and earnings, SOPH or MDXH?

Is SOPH or MDXH more profitable?

Do analysts recommend SOPH or MDXH?

Which has more volatility & risk, SOPH or MDXH?

Do insiders and institutionals believe in SOPH or MDXH?

Does the media refer more to SOPH or MDXH?

Summary

How does MDxHealth compare to KORU Medical Systems?

Which has more volatility and risk, KRMD or MDXH?

Which has better valuation & earnings, KRMD or MDXH?

Do institutionals & insiders have more ownership in KRMD or MDXH?

Is KRMD or MDXH more profitable?

Do analysts rate KRMD or MDXH?

Does the media favor KRMD or MDXH?

Summary

How does MDxHealth compare to Zepp Health?

Does the media refer more to ZEPP or MDXH?

Which has more risk & volatility, ZEPP or MDXH?

Do analysts prefer ZEPP or MDXH?

Which has stronger earnings & valuation, ZEPP or MDXH?

Is ZEPP or MDXH more profitable?

Do insiders and institutionals believe in ZEPP or MDXH?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MDXH vs. The Competition

MDxHealth Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools